The Clinton Foundation's Health Matters Initiative (CHMI) and the Johns Hopkins Bloomberg School of Public Health (JHSPH) were pleased to present a unique forum focused on elevating high-impact solutions to the nation's prescription opioid epidemic.
Building on the momentum and progress from last year's joint town hall, CHMI and JHSPH convened thought leaders from across industries and sectors to discuss evidence-based solutions designed to address the epidemic from a holistic approach. Speakers and panelists presented recommendations from cross-disciplinary work groups focused on areas ranging from community-based prevention strategies to addiction treatment initiatives. Those in attendance had the opportunity to engage in direct dialogue with each other as well as working-group leads through facilitated discussion modules.
In May 2014, a diverse group of experts - including clinicians, researchers, government officials, injury prevention professionals, law enforcement leaders, pharmaceutical manufacturers and distributors, lawyers, health insurers and patient representatives - gathered at the Johns Hopkins Bloomberg School of Public Health. The group convened to review what is known about the prescription opioid epidemic; to identify strategies for reversing the alarming trends in injuries and deaths from these drugs; and to make recommendations for action. In the months that followed, work groups reviewed the available evidence.
On January 13, 2016, several signatories of the report submitted a comment to the Docket of the Draft CDC Guideline for Prescribing Opioids for Chronic Pain. The comment, which is available here, emphasizes the urgency and importance of the proposed guidelines and discusses several concerns that have been raised by those opposing them.
2014 Prescription Drug Abuse Town Hall Highlights, 9.5 minutes
2014 Prescription Drug Abuse Town Hall, 1.5 hours
More information about the first town hall can be found at the official event page.